Matthew Pringle
Follow
Get notifications in MyBN when activity occurs.
Matthew Pringle
Non-Executive Director / Clinuvel Pharmaceuticals
Mr Pringle has experience in corporate finance, audit and assurance, governance and strategy, including over 25 years experience as a Partner at Pitcher Partners. His roles with Pitcher Partners included leading the corporate finance practice group, senior audit partner and leading the corporate governance and board advisory practice area.He is a director of Navalo Financial Services Group Limited, Hypersonix Launch Systems Limited, and the not-for-profit Anglicare Victoria.
Lists and Charts
Total Shareholder Return as at 29/11/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 1187th | Clinuvel Pharmaceuticals | -25% | -14% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Clinuvel Pharmaceuticals | $88.0m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEW ROLE: Non-Executive Director, Clinuvel Pharmaceuticals | 24 Sep 2024 |
